While President Donald Trump has promoted TrumpRX as a solution for patients seeking lower prescription drug costs, healthcare experts are raising red flags. The platform, a direct-to-patient purchasing marketplace, is designed to offer medications at discounted rates, but its structure may lead to unexpected costs for those accustomed to traditional insurance models.
According to Dr. William Soliman, CEO of the Accreditation Council for Medical Affairs, there are two primary financial pitfalls that consumers must understand before choosing this platform over their insurance provider.
1. The Illusion of “Savings” via List Prices
The most significant concern involves how TrumpRX presents its pricing. The platform typically displays a drug’s list price (the sticker price before any discounts) and compares it to the discounted price offered through the program.
Dr. Soliman warns that this comparison can be highly misleading for several reasons:
– Exaggerated Discounts: By using the list price as a benchmark, the platform makes its savings appear much larger than they actually are.
– Insurance Realities: Most patients with health insurance do not pay the full list price. Once a patient has met their annual deductible, their out-of-pocket cost is often a small, fixed copay.
– The Math Gap: A “discounted” cash price of $100 might look like a bargain compared to a $500 list price, but if an insured patient’s copay is only $25, the “discount” platform is actually four times more expensive.
2. The Deductible Trap
A second, more long-term financial risk involves how these payments are categorized by insurance companies.
When you purchase medication through a direct-to-consumer marketplace like TrumpRX, those payments do not count toward your insurance deductible. This distinction is vital for managing long-term healthcare costs:
- No Progress Toward Coverage: Every dollar spent on TrumpRX is “lost” in terms of your insurance progress. It does not help you reach the threshold required to trigger your full insurance benefits.
- Sustainability Issues: For patients—particularly older Americans—who require multiple chronic medications, this can lead to a cycle of high out-of-pocket spending that never contributes to their overall coverage limits.
The Changing Landscape of Prescription Access
The rise of platforms like TrumpRX coincides with a growing trend in the American healthcare system: increased denials from Medicare Advantage plans.
Many seniors are increasingly being told by their insurers to use coupons or direct-to-consumer marketplaces rather than receiving coverage through their standard plans. While these marketplaces offer an immediate way to bypass a denial, they may create a “hidden” financial burden by shifting the cost of care entirely onto the patient without the protections of traditional insurance.
“This might look like a great solution, but it may not be sustainable long term,” warns Dr. Soliman.
Conclusion
While TrumpRX offers an alternative for those denied coverage, users must compare the “discounted” price against their actual insurance copay and consider that these purchases will not help satisfy their annual insurance deductibles.
